标题
Albumin and its application in drug delivery
作者
关键词
-
出版物
Expert Opinion on Drug Delivery
Volume 12, Issue 5, Pages 793-812
出版商
Informa Healthcare
发表日期
2014-12-19
DOI
10.1517/17425247.2015.993313
参考文献
相关参考文献
注意:仅列出部分参考文献,下载原文获取全部文献信息。- The Human GLP-1 Analogs Liraglutide and Semaglutide: Absence of Histopathological Effects on the Pancreas in Nonhuman Primates
- (2014) C. F. Gotfredsen et al. DIABETES
- Safety and efficacy evaluation of albumin-bound paclitaxel
- (2014) Sara Cecco et al. Expert Opinion On Drug Safety
- Direct comparison of two albumin-based paclitaxel-loaded nanoparticle formulations: Is the crosslinked version more advantageous?
- (2014) Chunlei Li et al. INTERNATIONAL JOURNAL OF PHARMACEUTICS
- Dissection of the Neonatal Fc Receptor (FcRn)-Albumin Interface Using Mutagenesis and Anti-FcRn Albumin-blocking Antibodies
- (2014) Kine Marita Knudsen Sand et al. JOURNAL OF BIOLOGICAL CHEMISTRY
- Structural Insights into Neonatal Fc Receptor-based Recycling Mechanisms
- (2014) Vaheh Oganesyan et al. JOURNAL OF BIOLOGICAL CHEMISTRY
- Extending Serum Half-life of Albumin by Engineering Neonatal Fc Receptor (FcRn) Binding
- (2014) Jan Terje Andersen et al. JOURNAL OF BIOLOGICAL CHEMISTRY
- A clinical update of using albumin as a drug vehicle — A commentary
- (2014) Felix Kratz JOURNAL OF CONTROLLED RELEASE
- Pt(IV) Prodrugs Designed to Bind Non-Covalently to Human Serum Albumin for Drug Delivery
- (2014) Yao-Rong Zheng et al. JOURNAL OF THE AMERICAN CHEMICAL SOCIETY
- Novel Exenatide Analogs with Peptidic Albumin Binding Domains: Potent Anti-Diabetic Agents with Extended Duration of Action
- (2014) Odile E. Levy et al. PLoS One
- Unraveling the mysteries of serum albumin—more than just a serum protein
- (2014) Angelica M. Merlot et al. Frontiers in Physiology
- Nab-Paclitaxel for Metastatic Pancreatic Cancer: Clinical Outcomes and Potential Mechanisms of Action
- (2014) Salah-Eddin Al-Batran et al. Oncology Research and Treatment
- Human serum albumin from recombinant DNA technology: Challenges and strategies
- (2013) Zhen Chen et al. BIOCHIMICA ET BIOPHYSICA ACTA-GENERAL SUBJECTS
- Human serum albumin isoforms: Genetic and molecular aspects and functional consequences
- (2013) Ulrich Kragh-Hansen et al. BIOCHIMICA ET BIOPHYSICA ACTA-GENERAL SUBJECTS
- Novel insights into the pleiotropic effects of human serum albumin in health and disease
- (2013) Chung-Eun Ha et al. BIOCHIMICA ET BIOPHYSICA ACTA-GENERAL SUBJECTS
- Albumin as a versatile platform for drug half-life extension
- (2013) Darrell Sleep et al. BIOCHIMICA ET BIOPHYSICA ACTA-GENERAL SUBJECTS
- NMR reveals molecular interactions and dynamics of fatty acid binding to albumin
- (2013) James A. Hamilton BIOCHIMICA ET BIOPHYSICA ACTA-GENERAL SUBJECTS
- Albumin–drug interaction and its clinical implication
- (2013) Keishi Yamasaki et al. BIOCHIMICA ET BIOPHYSICA ACTA-GENERAL SUBJECTS
- Fatty acid binding to serum albumin: Molecular simulation approaches
- (2013) Shin-ichi Fujiwara et al. BIOCHIMICA ET BIOPHYSICA ACTA-GENERAL SUBJECTS
- Binding of transition metal ions to albumin: Sites, affinities and rates
- (2013) Wojciech Bal et al. BIOCHIMICA ET BIOPHYSICA ACTA-GENERAL SUBJECTS
- Orthogonal Assembly of a Designed Ankyrin Repeat Protein–Cytotoxin Conjugate with a Clickable Serum Albumin Module for Half-Life Extension
- (2013) Manuel Simon et al. BIOCONJUGATE CHEMISTRY
- Preparation and Characterization of Albumin Conjugates of a Truncated Peptide YY Analogue for Half-Life Extension
- (2013) George K. Ehrlich et al. BIOCONJUGATE CHEMISTRY
- Treatment innovations for metastatic breast cancer: Nanoparticle albumin-bound (NAB) technology targeted to tumors
- (2013) Ana Lluch et al. CRITICAL REVIEWS IN ONCOLOGY HEMATOLOGY
- Proteins: emerging carrier for delivery of cancer therapeutics
- (2013) Chetan Yewale et al. Expert Opinion on Drug Delivery
- Do Tregitopes have the potential to impact the current treatment landscape of autoimmune diseases?
- (2013) Anne S De Groot Expert Review of Clinical Immunology
- Transepithelial Transport of Fc-Targeted Nanoparticles by the Neonatal Fc Receptor for Oral Delivery
- (2013) E. M. Pridgen et al. Science Translational Medicine
- Crystal Structure of an HSA/FcRn Complex Reveals Recycling by Competitive Mimicry of HSA Ligands at a pH-Dependent Hydrophobic Interface
- (2013) Michael M. Schmidt et al. STRUCTURE
- Poly-S-Nitrosated Albumin as a Safe and Effective Multifunctional Antitumor Agent: Characterization, Biochemistry and Possible Future Therapeutic Applications
- (2013) Yu Ishima et al. Biomed Research International
- THE ALBUMIN-BINDING DOMAIN AS A SCAFFOLD FOR PROTEIN ENGINEERING
- (2013) Johan Nilvebrant et al. Computational and Structural Biotechnology Journal
- Challenges in Development of Nanoparticle-Based Therapeutics
- (2012) Neil Desai AAPS Journal
- S-Nitrosated Human Serum Albumin Dimer is not only a Novel Anti-Tumor Drug but also a Potentiator for Anti-Tumor Drugs with Augmented EPR Effects
- (2012) Yu Ishima et al. BIOCONJUGATE CHEMISTRY
- Selective delivery of interleukine-1 receptor antagonist to inflamed joint by albumin fusion
- (2012) Mengyuan Liu et al. BMC BIOTECHNOLOGY
- RGD-conjugated albumin nanoparticles as a novel delivery vehicle in pancreatic cancer therapy
- (2012) Shunrong Ji et al. CANCER BIOLOGY & THERAPY
- Insulin degludec: overview of a novel ultra long-acting basal insulin
- (2012) S. C. L. Gough et al. DIABETES OBESITY & METABOLISM
- An overview of the pharmacokinetics, efficacy and safety of liraglutide
- (2012) Bruce Bode DIABETES RESEARCH AND CLINICAL PRACTICE
- The Immunologic Functions of the Neonatal Fc Receptor for IgG
- (2012) Timo Rath et al. JOURNAL OF CLINICAL IMMUNOLOGY
- In Vitro and In Vivo Studies of IgG-derived Treg Epitopes (Tregitopes): A Promising New Tool for Tolerance Induction and Treatment of Autoimmunity
- (2012) Leslie P. Cousens et al. JOURNAL OF CLINICAL IMMUNOLOGY
- Weeklynab-Paclitaxel in Combination With Carboplatin Versus Solvent-Based Paclitaxel Plus Carboplatin as First-Line Therapy in Patients With Advanced Non–Small-Cell Lung Cancer: Final Results of a Phase III Trial
- (2012) Mark A. Socinski et al. JOURNAL OF CLINICAL ONCOLOGY
- Nanobody-albumin nanoparticles (NANAPs) for the delivery of a multikinase inhibitor 17864 to EGFR overexpressing tumor cells
- (2012) Isil Altintas et al. JOURNAL OF CONTROLLED RELEASE
- Bicyclization and Tethering to Albumin Yields Long-Acting Peptide Antagonists
- (2012) Alessandro Angelini et al. JOURNAL OF MEDICINAL CHEMISTRY
- Biophysical Characterization and Stabilization of the Recombinant Albumin Fusion Protein sEphB4–HSA
- (2012) Shuai Shi et al. JOURNAL OF PHARMACEUTICAL SCIENCES
- Selective Domain Stabilization as a Strategy to Reduce Human Serum Albumin–Human Granulocyte Colony Stimulating Factor Aggregation Rate
- (2012) Amanda A. Cordes et al. JOURNAL OF PHARMACEUTICAL SCIENCES
- Selective Domain Stabilization as a Strategy to Reduce Fusion Protein Aggregation
- (2012) Amanda A. Cordes et al. JOURNAL OF PHARMACEUTICAL SCIENCES
- RGD-Based Strategies To Target Alpha(v) Beta(3) Integrin in Cancer Therapy and Diagnosis
- (2012) Fabienne Danhier et al. MOLECULAR PHARMACEUTICS
- Structure-based mutagenesis reveals the albumin-binding site of the neonatal Fc receptor
- (2012) Jan Terje Andersen et al. Nature Communications
- Review of the Therapeutic Uses of Liraglutide
- (2011) Gina J. Ryan et al. CLINICAL THERAPEUTICS
- Impact of albumin on drug delivery — New applications on the horizon
- (2011) Bakheet Elsadek et al. JOURNAL OF CONTROLLED RELEASE
- Clinical impact of serum proteins on drug delivery
- (2011) Felix Kratz et al. JOURNAL OF CONTROLLED RELEASE
- Human serum albumin: From bench to bedside
- (2011) Gabriella Fanali et al. MOLECULAR ASPECTS OF MEDICINE
- Efficient mucosal vaccination mediated by the neonatal Fc receptor
- (2011) Lilin Ye et al. NATURE BIOTECHNOLOGY
- Lactosaminated human albumin, a hepatotropic carrier of drugs
- (2010) Luigi Fiume et al. EUROPEAN JOURNAL OF PHARMACEUTICAL SCIENCES
- Native albumin for targeted drug delivery
- (2010) Elena Neumann et al. Expert Opinion on Drug Delivery
- Antibodies against Gluco-Oxidatively Modified Human Serum Albumin Detected in Diabetes-Associated Complications
- (2010) Mohd. Wajid Ali Khan et al. INTERNATIONAL ARCHIVES OF ALLERGY AND IMMUNOLOGY
- Clinical Ramifications of the MHC Family Fc Receptor FcRn
- (2010) Derry C. Roopenian et al. JOURNAL OF CLINICAL IMMUNOLOGY
- Neonatal Fc Receptor: From Immunity to Therapeutics
- (2010) Timothy T. Kuo et al. JOURNAL OF CLINICAL IMMUNOLOGY
- Pharmacokinetics of 5-Aminofluorescein-Albumin, a Novel Fluorescence Marker of Brain Tumors During Surgery
- (2010) Reinhard Ding et al. JOURNAL OF CLINICAL PHARMACOLOGY
- Beware of Antibodies to Dietary Proteins in "Antigen-specific" Immunoassays! Falsely Positive Anticytokine Antibody Tests Due to Reactivity with Bovine Serum Albumin in Rheumatoid Arthritis (The Swedish TIRA Project)
- (2010) C. SJOWALL et al. JOURNAL OF RHEUMATOLOGY
- Cubilin Is Essential for Albumin Reabsorption in the Renal Proximal Tubule
- (2010) S. Amsellem et al. JOURNAL OF THE AMERICAN SOCIETY OF NEPHROLOGY
- Adnectins: engineered target-binding protein therapeutics
- (2010) D. Lipovsek PROTEIN ENGINEERING DESIGN & SELECTION
- New Strategy for the Extension of the Serum Half-Life of Antibody Fragments
- (2009) Sabrina Trüssel et al. BIOCONJUGATE CHEMISTRY
- Ligand binding strategies of human serum albumin: How can the cargo be utilized?
- (2009) Ankita Varshney et al. CHIRALITY
- Albinterferon alfa-2b, a novel fusion protein of human albumin and human interferon alfa-2b, for chronic hepatitis C
- (2009) Vinod K. Rustgi CURRENT MEDICAL RESEARCH AND OPINION
- Albumin as a Nitric Oxide-Traffic Protein: Characterization, Biochemistry and Possible Future Therapeutic Applications
- (2009) Yu Ishima et al. Drug Metabolism and Pharmacokinetics
- The Versatile MHC Class I-related FcRn Protects IgG and Albumin from Degradation: Implications for Development of New Diagnostics and Therapeutics
- (2009) Jan Terje Andersen et al. Drug Metabolism and Pharmacokinetics
- Cross-species Binding Analyses of Mouse and Human Neonatal Fc Receptor Show Dramatic Differences in Immunoglobulin G and Albumin Binding
- (2009) Jan Terje Andersen et al. JOURNAL OF BIOLOGICAL CHEMISTRY
- Structure, Properties, and Engineering of the Major Zinc Binding Site on Human Albumin
- (2009) Claudia A. Blindauer et al. JOURNAL OF BIOLOGICAL CHEMISTRY
- Molecular Mechanisms of Receptor-Mediated Endocytosis in the Renal Proximal Tubular Epithelium
- (2009) Akihiko Saito et al. JOURNAL OF BIOMEDICINE AND BIOTECHNOLOGY
- Immune and non-immune functions of the (not so) neonatal Fc receptor, FcRn
- (2009) Kristi Baker et al. Seminars in Immunopathology
- Targeted drug delivery by in vivo coupling to endogenous albumin: an albumin-binding prodrug of methotrexate (MTX) is better than MTX in the treatment of murine collagen-induced arthritis
- (2008) C Fiehn et al. ANNALS OF THE RHEUMATIC DISEASES
- Altered chain-length and glycosylation modify the pharmacokinetics of human serum albumin
- (2008) Yasunori Iwao et al. BIOCHIMICA ET BIOPHYSICA ACTA-PROTEINS AND PROTEOMICS
- An Albumin-Exendin-4 Conjugate Engages Central and Peripheral Circuits Regulating Murine Energy and Glucose Homeostasis
- (2008) Laurie L. Baggio et al. GASTROENTEROLOGY
- Mutations and polymorphisms of the gene of the major human blood protein, serum albumin
- (2008) Lorenzo Minchiotti et al. HUMAN MUTATION
- Albumin-conjugated C34 Peptide HIV-1 Fusion Inhibitor
- (2008) Cheryl A. Stoddart et al. JOURNAL OF BIOLOGICAL CHEMISTRY
- Albumin as a drug carrier: Design of prodrugs, drug conjugates and nanoparticles
- (2008) Felix Kratz JOURNAL OF CONTROLLED RELEASE
- Improved tumor targeting of anti-epidermal growth factor receptor Nanobodies through albumin binding: taking advantage of modular Nanobody technology
- (2008) B. M. Tijink et al. MOLECULAR CANCER THERAPEUTICS
- Biodistribution and tumor imaging of an anti-CEA single-chain antibody–albumin fusion protein
- (2008) Paul J. Yazaki et al. NUCLEAR MEDICINE AND BIOLOGY
- Anti-serum albumin domain antibodies for extending the half-lives of short lived drugs
- (2008) L. J. Holt et al. PROTEIN ENGINEERING DESIGN & SELECTION
- Engineering of a femtomolar affinity binding protein to human serum albumin
- (2008) A. Jonsson et al. PROTEIN ENGINEERING DESIGN & SELECTION
Add your recorded webinar
Do you already have a recorded webinar? Grow your audience and get more views by easily listing your recording on Peeref.
Upload NowAsk a Question. Answer a Question.
Quickly pose questions to the entire community. Debate answers and get clarity on the most important issues facing researchers.
Get Started